Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
Key Data:
Drug (Brand/Generic)
Ariflo (cilomilast)
Company/Licensee
GlaxoSmithKline Pharmaceuticals
Therapy Class
PDE-IV inhibitor
Product Description
Oral selective phosphodiesterase (PDE) IV inhibitor
Current Indication
Treatment of COPD
Market Sector
Respiratory
Development Status
Pre-registration
